Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Lung Yu

Showing results (281-290 of 527) with videos related to

Pageof 53
Sort By:
Plos Genetics|June 20, 2019
Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antiviralsShira Perez, Antony Kaspi, Tom Domovitz, et al.
Journal of Gastroenterology and Hepatology|May 25, 2010
Early identification of achieving a sustained virological response in chronic hepatitis C patients without a rapid virological responseChung-Feng Huang, Jeng-Fu Yang, Jee-Fu Huang, et al.
Hepatology International|July 24, 2015
Interferon-associated hepatic steatosis is related to discrepancies in biochemical and virological responses of chronic hepatitis C to IFN-based therapyChun-Hao Chen, Jee-Fu Huang, Chung-Feng Huang, et al.
Hepatology International|May 19, 2021
Resubclassification and clinical management for Barcelona Clinic Liver Cancer Stage C hepatocellular carcinomaChih-Wen Lin, Yaw-Sen Chen, Gin-Ho Lo, et al.
Hepatology (Baltimore, Md.)|May 30, 2008
Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trialMing-Lung Yu, Chia-Yen Dai, Jee-Fu Huang, et al.
Oncotarget|March 16, 2018
The IL-6/STAT3 pathway upregulates microRNA-125b expression in hepatitis C virus infectionChia-Yen Dai, Yi-Shan Tsai, Wen-Wen Chou, et al.
Hepatology (Baltimore, Md.)|November 1, 2012
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversionHung-Chih Yang, Chi-Ling Chen, Yueh-Chi Shen, et al.
The Kaohsiung Journal of Medical Sciences|October 6, 2020
Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancyMing-Lun Yeh, Hsing-Tao Kuo, Ching-I Huang, et al.
Medicine|October 27, 2015
Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized StudyMing-Lun Yeh, Ming-Yen Hsieh, Ching-I Huang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 12, 2017
Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in TaiwanMeng-Hsuan Hsieh, Ming-Lun Yeh, Tung-Hung Su, et al.
Pageof 53

Showing results (281-290 of 527) with videos related to

Sort By:
Pageof 53
Plos Genetics|June 20, 2019
Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antiviralsShira Perez, Antony Kaspi, Tom Domovitz, et al.
Journal of Gastroenterology and Hepatology|May 25, 2010
Early identification of achieving a sustained virological response in chronic hepatitis C patients without a rapid virological responseChung-Feng Huang, Jeng-Fu Yang, Jee-Fu Huang, et al.
Hepatology International|July 24, 2015
Interferon-associated hepatic steatosis is related to discrepancies in biochemical and virological responses of chronic hepatitis C to IFN-based therapyChun-Hao Chen, Jee-Fu Huang, Chung-Feng Huang, et al.
Hepatology International|May 19, 2021
Resubclassification and clinical management for Barcelona Clinic Liver Cancer Stage C hepatocellular carcinomaChih-Wen Lin, Yaw-Sen Chen, Gin-Ho Lo, et al.
Hepatology (Baltimore, Md.)|May 30, 2008
Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trialMing-Lung Yu, Chia-Yen Dai, Jee-Fu Huang, et al.
Oncotarget|March 16, 2018
The IL-6/STAT3 pathway upregulates microRNA-125b expression in hepatitis C virus infectionChia-Yen Dai, Yi-Shan Tsai, Wen-Wen Chou, et al.
Hepatology (Baltimore, Md.)|November 1, 2012
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversionHung-Chih Yang, Chi-Ling Chen, Yueh-Chi Shen, et al.
The Kaohsiung Journal of Medical Sciences|October 6, 2020
Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancyMing-Lun Yeh, Hsing-Tao Kuo, Ching-I Huang, et al.
Medicine|October 27, 2015
Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized StudyMing-Lun Yeh, Ming-Yen Hsieh, Ching-I Huang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 12, 2017
Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in TaiwanMeng-Hsuan Hsieh, Ming-Lun Yeh, Tung-Hung Su, et al.
Pageof 53